These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22960279)

  • 21. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
    J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M; Lee LN; Evans GF; Zuckerman SH
    J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
    Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
    Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
    Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
    Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of autoimmunity by organochlorine pesticides: a comparison of splenic B-cell effects of chlordecone and estradiol in (NZBxNZW)F1 mice.
    Wang F; Roberts SM; Butfiloski EJ; Morel L; Sobel ES
    Toxicol Sci; 2007 Sep; 99(1):141-52. PubMed ID: 17578864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
    Liu N; Ohnishi N; Ni L; Akira S; Bacon KB
    Nat Immunol; 2003 Jul; 4(7):687-93. PubMed ID: 12766768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells.
    Aranburu A; Ceccarelli S; Giorda E; Lasorella R; Ballatore G; Carsetti R
    J Immunol; 2010 Dec; 185(12):7293-301. PubMed ID: 21078901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cells from common variable immunodeficiency patients fail to differentiate to antibody secreting cells in response to TLR9 ligand (CpG-ODN) or anti-CD40+IL21.
    Clemente A; Pons J; Matamoros N; Iglesias J; Ferrer JM
    Cell Immunol; 2011; 268(1):9-15. PubMed ID: 21296339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune complex negatively regulates Toll-like receptor 9-mediated immune responses in B cells through the inhibitory Fc-gamma receptor IIb.
    Qian L; Chen W; Qin H; Rui C; Jia X; Fu Y; Gong W; Tian F; Ji M
    Microbiol Immunol; 2015 Mar; 59(3):142-51. PubMed ID: 25557539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
    Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
    J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell.
    Xu L; Wang C; Wen Z; Yao X; Liu Z; Li Q; Wu Z; Xu Z; Liang Y; Ren T
    Immunol Lett; 2010 Jan; 127(2):93-9. PubMed ID: 19854217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice.
    Jiang B; Sun L; Hao S; Li X; Xu Y; Hou Y
    Immunol Invest; 2008; 37(3):227-43. PubMed ID: 18389442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells.
    Yurino H; Ishikawa S; Sato T; Akadegawa K; Ito T; Ueha S; Inadera H; Matsushima K
    Toxicol Sci; 2004 Sep; 81(1):139-47. PubMed ID: 15166399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
    Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
    J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.